📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Prismic Pharmaceuticals

1.1 - Company Overview

Prismic Pharmaceuticals Logo

Prismic Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel prescription medical drugs for inflammatory diseases and prescription medical foods for the clinical dietary management of metabolic processes associated with disorders common in the aging 'baby boomer' population, including central nervous system disorders.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Prismic Pharmaceuticals

Oxford Biomedica Logo

Oxford Biomedica

HQ: United Kingdom Website
  • Description: Provider of gene and cell therapy solutions, offering lentiviral LentiVector and AAV platforms for development and manufacturing of gene therapies, plus CDMO services for viral vectors including tech transferred-in execution of client-defined methods, process development, GMP manufacturing, and regulatory support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxford Biomedica company profile →
Jnana Therapeutics Logo

Jnana Therapeutics

HQ: United States Website
  • Description: Provider of chemoproteomics-driven drug discovery via its RAPID platform to identify small-molecule medicines for a range of diseases; developing JNT-517, an allosteric SLC6A19 inhibitor for phenylketonuria to reduce plasma phenylalanine; advancing programs for autoimmune and inflammatory conditions; and collaborating with biopharma in cancer, immune-mediated, and neurological diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jnana Therapeutics company profile →
Rexahn Pharmaceuticals Logo

Rexahn Pharmaceuticals

HQ: United States Website
  • Description: Provider of treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rexahn Pharmaceuticals company profile →
Lilly Logo

Lilly

HQ: United States Website
  • Description: Provider of medicines for diabetes, cancer, immunology, and other major health areas, including insulin products with affordability initiatives ($35 or less/month); Efsitora for type 2 diabetes via autoinjector; EBGLYSS for moderate-to-severe atopic dermatitis; Jaypirca for relapsed/refractory MCL and CLL/SLL; Zepbound (tirzepatide) for obesity; Verzenio for HR+, HER2- early breast cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lilly company profile →
Purdue Pharma Logo

Purdue Pharma

HQ: United States Website
  • Description: Provider of medications and consumer health products for healthcare professionals, patients, consumers, and caregivers; develops, manufactures, and markets prescription opioid analgesics for pain management and over-the-counter medications including laxatives, antiseptics, and dietary supplements; offers public health initiatives; and conducts research and development of medications for cancer and central nervous system disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Purdue Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Prismic Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Prismic Pharmaceuticals

2.2 - Growth funds investing in similar companies to Prismic Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Prismic Pharmaceuticals

4.2 - Public trading comparable groups for Prismic Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Prismic Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Prismic Pharmaceuticals

What does Prismic Pharmaceuticals do?

Prismic Pharmaceuticals is a provider of novel prescription medical drugs for inflammatory diseases and prescription medical foods for the clinical dietary management of metabolic processes associated with disorders common in the aging 'baby boomer' population, including central nervous system disorders.

Who are Prismic Pharmaceuticals's competitors?

Prismic Pharmaceuticals's competitors and similar companies include Oxford Biomedica, Jnana Therapeutics, Rexahn Pharmaceuticals, Lilly, and Purdue Pharma.

Where is Prismic Pharmaceuticals headquartered?

Prismic Pharmaceuticals is headquartered in United States.

How many employees does Prismic Pharmaceuticals have?

Prismic Pharmaceuticals has 1,000 employees 🔒.

When was Prismic Pharmaceuticals founded?

Prismic Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Prismic Pharmaceuticals in?

Prismic Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Prismic Pharmaceuticals

Who are the top strategic acquirers in Prismic Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Prismic Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Prismic Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Prismic Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Prismic Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Prismic Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Prismic Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Prismic Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Prismic Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Prismic Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Prismic Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Prismic Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Prismic Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Prismic Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Prismic Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Prismic Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Prismic Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Prismic Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Prismic Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Prismic Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Prismic Pharmaceuticals